Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Alopecia areata causes patchy hair loss due to unknown factors, affecting all ages and genders.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

Methotrexate with corticosteroids can help regrow hair in severe alopecia areata but may cause relapses and side effects.

Reflectance confocal microscopy is a promising non-invasive tool for diagnosing alopecia areata incognita.

Children with alopecia areata often face more stress and depression, especially related to separation, which can affect their condition.

Baricitinib 4 mg should be used for at least 1 year to see significant hair regrowth in severe alopecia areata.

Improving oral health may help hair regrowth in children with alopecia areata.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Alopecia areata is linked to thyroid diseases, and thyroid testing may help affected patients.

Distinct miRNA signatures could help diagnose and treat severe Alopecia Areata.

More severe alopecia areata can lower quality of life.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Alopecia areata is increasing globally, with disparities needing better prevention and support.

Early recognition and thyroid evaluation are crucial for managing diffuse alopecia areata linked to autoimmune thyroid disease.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.

Alopecia areata cases in children are rising, especially in females and low-income regions, with a projected increase in China and decrease in the USA.

Triamcinolone acetonide is more effective than cryotherapy for hair regrowth in alopecia areata but has different side effects.

Alopecia Areata patients have low zinc and high copper levels.

Nail changes are common in alopecia areata and can indicate its severity.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Both treatments help hair regrowth, but Botulinum Toxin-A has fewer side effects.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

Ayurvedic treatment may help manage alopecia areata.

Ayurvedic treatment successfully regrew hair in a 19-year-old with alopecia areata in 2 months.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

SQSTM1 gene issues may increase the risk of alopecia areata.